Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon beta-1a and functional brain adaptation in multiple sclerosis
NL-OMON35491Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Nov 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of interferon beta-1a in multiple sclerosis (MS) (4 arms), sponsored by Vrije University Medical Center. Primary endpoint: Change from baseline in resting-state functional connectivity fMRI at month 24. Started Nov 2011; status: active, not recruiting.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON35491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35491.